Weil – Abax Global Capital in Deal to Take Fushi Copperweld Private

Chinese metallic wire manufacturer Fushi Copperweld Inc. announced that is has agreed to be taken private by an investment group led by its co-chief executive, Li Fu, and private equity firm Abax Global Capital (Hong Kong) Ltd. for $364 million. The per share price of $9.50 represents a 21 percent premium on the stock’s closing price on June 28.

More >>

Tags:  Weil, Gotshal & Manges, LLP | Hong Kong

Paul Hastings Advises the Underwriters in Huadian Fuxin’s Hong Kong Listing

Paul Hastings, a leading global law firm, announced today that it represented CITIC Securities, UBS and Bank of America Merrill Lynch as the Joint Global Coordinators in Huadian Fuxin Energy Corporation Limited’s (“Huadian Fuxin”) US$319 million global offering and listing of its H-shares on the Hong Kong Stock Exchange. The transaction comprised a Hong Kong public offering and a Reg S/Rule 144A international offering.

More >>

Tags:  Paul Hastings, LLP | Hong Kong

Simpson Thacher Represents Underwriters in Offering of US$188 Million Principal Amount of Zero Coupon Convertible Bonds by Zhen Ding Technology Holding Limited

The Hong Kong office of the Firm represented the underwriters, led by Citibank Global Markets Limited, DBS Bank Limited, Merrill Lynch Far East Limited and Standard Chartered Bank, in the offering of US$188 million principal amount of Zero Coupon Convertible Bonds (the “Bonds”) by Zhen Ding Technology Holding Limited (“Zhen Ding”). Zhen Ding is a leading designer and manufacturer of printed circuit boards to leading brand name customers. The common shares of Zhen Ding are traded on the Taiwan Stock Exchange under the trading code “4958”. The Bonds are listed on the Singapore Stock Exchange.

More >>

Tags:  Simpson Thacher & Bartlett LLP | Hong Kong

Davis Polk Advises Novast Holdings on Its Strategic Partnership with Eli Lilly

Davis Polk advised Novast Holdings Limited in connection with its strategic partnership with Eli Lilly and Company. The parties entered into a license and supply agreement, pursuant to which Novast granted Lilly an exclusive license to commercialize certain pharmaceutical products in People’s Republic of China, Hong Kong and Macau. Novast has committed to set up a platform to support Lilly-branded generic products and increase the manufacturing capacity at its Nantong site over the next several years, with Lilly providing technical support to enhance quality standards. Lilly also made a new investment in Novast and increased its equity position in Novast by $20 million.

More >>

Tags:  Davis Polk & Wardwell LLP | Hong Kong

Paul Hastings Advises Mapletree Investments on Establishment of US$3 Billion Euro Medium Term Note Programme

Paul Hastings, a leading global law firm, announced today that it represented Mapletree Treasury Services Limited and Mapletree Treasury Services (HKSAR) Private Limited as issuers (the “Issuers”) and Mapletree Investments Pte Ltd. as guarantor (the “Guarantor”) on the establishment of a US$3 billion guaranteed Euro Medium Term Note Programme by the Issuers (the “EMTN Programme”). The Guarantor is a leading Asia-focused real estate developer and capital management company headquartered in Singapore with SGD19.9 billion assets under management.

More >>

Tags:  Paul Hastings, LLP | Hong Kong

Freshfields Advises the London Metal Exchange on Its £1.388bn Acquisition by Hong Kong Exchanges & Clearing Limited

International law firm Freshfields Bruckhaus Deringer has advised LME Holdings Limited, the parent company of The London Metal Exchange Limited (the “LME”), on the £1,388bn recommended cash offer for its entire issued and outstanding ordinary share capital by a wholly- owned subsidiary of Hong Kong Exchanges & Clearing Ltd (“HKEx”) (the “Transaction”). The Transaction brings together the LME, the world’s leading non-ferrous base metals exchange trading venue with the leading operator of exchanges and clearing houses in Asia.

More >>

Tags:  Freshfields LLP | Hong Kong